Antisense and RNAi Therapeutics Market: by Technology (RNAi [miRNA, and siRNA], and Antisense RNA), by Route of Administration (Pulmonary, Intravenous, Intra-Dermal, Intra-Peritoneal, Topical, and Others), and by Indication (Oncology, Cardiovascular Diseases, Renal Diseases, Neurodegenerative Diseases, Respiratory Diseases, Genetic Diseases, Infectious Diseases, and Other Disease Indications): Global Industry Perspective, Comprehensive Analysis and Forecast, 2019 – 2025
Published Date: 07-Nov-2019Healthcare
Category: Report Format : PDF
Report Code: ZMR-4980
Status : Published
According to the report, the global demand for antisense and RNAi therapeutics market was valued at approximately USD 1,023.0 million in 2018 and is expected to generate revenue of around USD 1,928.9 million by end of 2025, growing at a CAGR of around 8.3% between 2019 and 2025.